文献速递衰弱、肌少症与跌倒多重用药老年慢病共病管理

NFE2L2基因单核苷酸多态性与老年人药物不良反应、多病共存及衰弱的关联

The Association of a Single-Nucleotide Polymorphism in the Nuclear Factor (Erythroid-Derived 2)-Like 2 Gene With Adverse Drug Reactions, Multimorbidity, and Frailty in Older People.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2020-01-01

本研究检验人类衰老中Nrf2基因(NFE2L2)转录/翻译下降及该基因SNP与老年人药物不良反应(ADR)风险、多病共存和衰弱相关的假说。在18-80岁健康人外周血单核细胞中,NFE2L2基因和Nrf2蛋白表达随年龄显著下降;在PRIME研究亚组中,rs35652124 SNP与ADR风险增加及衰弱和多病共存评分降低相关。

要点

  • 人外周血单核细胞中NFE2L2基因和Nrf2蛋白表达随年龄显著下降。
  • PRIME亚组中rs35652124 SNP与ADR风险增加相关。
  • 该SNP同时与衰弱和多病共存评分降低相关。

核心结论

  • NFE2L2基因及Nrf2蛋白表达随人类年龄增长而显著下降。
  • rs35652124 NFE2L2 SNP与老年人ADR风险增加及衰弱和多病共存评分降低相关。

研究设计与样本

  • 在18-80岁健康人外周血单核细胞中测定基因表达和蛋白水平。
  • 在PRIME研究(多中心前瞻性队列,随访出院后8周以判定ADR)亚组中测定三个位点的NFE2L2基因型。

主要发现

  • 人外周血单核细胞中NFE2L2基因和Nrf2蛋白表达随年龄显著下降。
  • PRIME亚组中rs35652124 NFE2L2 SNP与ADR风险增加相关。
  • 该SNP与衰弱评分降低和多病共存评分降低相关。

关键数值与推荐

  • NFE2L2基因型在三个位点测定。
  • PRIME研究随访老年人在出院后8周以判定ADR。

临床怎么用

  • rs35652124等NFE2L2 SNP有望帮助识别ADR风险增加的老年人以进行分层干预。
  • Nrf2表达随龄下降提示其作为衰老相关应激反应标志的潜在价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Susceptibility to adverse drug reactions (ADRs), multimorbidity, and frailty are associated with human aging, yet there is wide variation in the severity and age at which individuals are afflicted. Identifying genetic markers of increased risk of this phenotype would help stratify individuals to specialist interventions. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) regulates a cell's response to stressors, including the expression of enzymes involved in drug metabolism. Its expression has been shown to decline in animal aging models. In this study, we tested the hypothesis that Nrf2 gene (NFE2L2) transcription/translation decline in human aging and that single-nucleotide polymorphisms (SNPs) in the NFE2L2 gene are associated with increased ADR risk, multimorbidity, and frailty in older people. Gene expression and protein levels were measured in peripheral blood mononuclear cells donated from healthy patients aged 18-80 years old. NFE2L2 genotypes were determined at three loci in a subpopulation of patients recruited to the PRIME study (a multicenter prospective cohort study that followed older adults for 8 weeks post-discharge to determine ADR). Both NFE2L2 gene and Nrf2 protein expression declined significantly with age in human peripheral blood mononuclear cells. In the PRIME substudy population, the rs35652124 NFE2L2 SNP was associated with increased ADR risk and decreased frailty and multimorbidity scores.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Scutt G, Overall A, Bakrania P, et al. The Association of a Single-Nucleotide Polymorphism in the Nuclear Factor (Erythroid-Derived 2)-Like 2 Gene With Adverse Drug Reactions, Multimorbidity, and Frailty in Older People. J Gerontol A Biol Sci Med Sci. 2020. PMID: 31102514. doi:10.1093/gerona/glz131

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。